Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineered Nanovaccine Targeting Clec9a+ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist
Shanshan Gou, Wenwen Liu, Shuai Wang, et al.
Nano Letters (2021) Vol. 21, Iss. 23, pp. 9939-9950
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 207
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 66
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Autophagosomes coated in situ with nanodots act as personalized cancer vaccines
Weiqiang Huang, Wei You, Ya-Qi Zhu, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
Vaccine adjuvants to engage the cross-presentation pathway
Woo‐Jong Lee, M. Suresh
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection
Yuan‐Bo Pan, Wei Tang, Wenpei Fan, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 23, pp. 9759-9830
Open Access | Times Cited: 62
Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy
Wen Song, Shujun Song, Jing Kuang, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 15977-15993
Closed Access | Times Cited: 49
Manganese Dioxide-Entrapping Dendrimers Co-Deliver Protein and Nucleotide for Magnetic Resonance Imaging-Guided Chemodynamic/Starvation/Immune Therapy of Tumors
Yue Gao, Zhijun Ouyang, Siyan Shen, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23889-23902
Closed Access | Times Cited: 38
Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives
Cuiqing Huang, Ni Shao, Yanyu Huang, et al.
Materials Today Bio (2023) Vol. 23, pp. 100839-100839
Open Access | Times Cited: 36
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 35
Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy
Liuzhou Mao, Panqin Ma, Xi Luo, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 9826-9849
Closed Access | Times Cited: 34
Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy
Yongjuan Li, Xinyan Li, Jinmeng Yi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 33
Targeting dendritic cells to advance cross-presentation and vaccination outcomes
Christophe Macri, Devi Jenika, Cassandra Ouslinis, et al.
Seminars in Immunology (2023) Vol. 68, pp. 101762-101762
Closed Access | Times Cited: 30
Photothermal-triggered dendrimer nanovaccines boost systemic antitumor immunity
Siyan Shen, Yue Gao, Zhijun Ouyang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 171-183
Closed Access | Times Cited: 28
Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy
Qingbin He, Runxiao Zheng, Junchi Ma, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 24
Radiotherapy-activated tumor immune microenvironment: Realizing radiotherapy-immunity combination therapy strategies
Haifen Luo, Wen Ma, Qi Chen, et al.
Nano Today (2023) Vol. 53, pp. 102042-102042
Closed Access | Times Cited: 23
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 12
The role of dendritic cells in cancer immunity and therapeutic strategies
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 11
Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment
Zhao Guo, Shuhang Wang, Guangjun Nie, et al.
Med (2024) Vol. 5, Iss. 7, pp. 660-688
Closed Access | Times Cited: 9
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
Jiawen Zhang, Sihui Yu, Qiao Peng, et al.
Cancer Biology and Medicine (2024), pp. 1-20
Open Access | Times Cited: 8
Tumor Vaccine Exploiting Membranes with Influenza Virus-Induced Immunogenic Cell Death to Decorate Polylactic Coglycolic Acid Nanoparticles
Ying Yang, Yongmao Hu, Ying Yang, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
Meihua Yu, Wei Yang, Wenwen Yue, et al.
Advanced Science (2022) Vol. 9, Iss. 35
Open Access | Times Cited: 37
A PD-L1 and VEGFR2 dual targeted peptide and its combination with irradiation for cancer immunotherapy
Ling Jiao, Qingyu Dong, Wenjie Zhai, et al.
Pharmacological Research (2022) Vol. 182, pp. 106343-106343
Closed Access | Times Cited: 28
Supramolecular Cyclic Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy
Li Xu, Hongping Deng, Liang Wu, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 10090-10103
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top